Barbara Hirschman Chaiyachati, MD’15, PhD’13, a Pediatric Fellow at the Children’s Hospital of Philadelphia wrote “Additional accomplishment during residency: becoming the mother of two boys.”
Dylan Davey, MD’14, PhD’14, has matched into Trauma/Surgical Critical Care Fellowship at Medstar Washington Hospital Center in DC starting August 2019.
Nicholas Theodosakis, MD’17, PhD’15, Winner: "Rising Derm Stars" competition at the 2018 Fall Clinical Dermatology Conference. He also has a new first-author publication:
Theodosakis N, Langdon CG, Micevic G, Krykbaeva I, Means RE, Stern DF, Bosenberg MW.Inhibition of isoprenylation synergizes with MAPK blockade to prevent growth in treatment-resistant melanoma, colorectal, and lung cancer. Pigment Cell Melanoma Res. 2018 Oct 3. doi: 10.1111/pcmr.12742. [Epub ahead of print]
(other Yale MD-PhD students also bolded)
Joshua Motelow, MD’15, PhD’15, wrote “After enjoying my pediatric residency at New York-Presbyterian Columbia, I'm now a first-year Pediatric Critical Care Medicine fellow at Columbia. My research interests are focused on the contribution of rare Mendelian variants to disease.”
Christopher Bartley, MD’15, PhD’15, received an NIMH Outstanding Resident Award in 2017 and is currently Chief Resident of Education in the Department of Psychiatry at UCSF. He won a 2018 PGY-3 Medical Student Teaching Award in the Department of Psychiatry, and is being co-mentored for his resident research fellowship in the Departments of Psychiatry & Neurology by Drs. Sam Pleasure MD,PhD and Michael Wilson, MD.
James Goldenring, MD’86, PhD’84, is Program Director for the Burroughs Welcome Physician Scientist Institutional Award “Supporting Research Careers for Interventional Physicians and Surgeons (SCRIPS)” project at Vanderbilt School of Medicine. This award program of the Burroughs Welcome Fund provides $2.5 million to five institutions in the US and Canada to address gaps and issues in the physician-scientist pipeline.
Mark Lipian MD’86, PhD’85,i s an internationally recognized Forensic Psychiatrist, known for having introduced the concept of Personality Disorder into conflicts and/or evaluations of fitness-for-duty/dangerousness in political, workplace, and academic settings. He isan expert on Malingering, Post-traumatic Stress Disorder; and the Personality Disorders (both on treatment and on manifestation in forensic contexts), and has lectured internationally and nationally on these topics. Mark has written several textbook chapters on these disorders, including several in varying editions of the Kaplan and Sadock Textbooks.
Daniel Saal, MD’97, PhD’98, works as a psychiatrist in addiction medicine. He writes, “I was in the past an assistant professor at Emory. I was able to make the transition from resident/fellow to assistant professor and then to the non-academic clinical world. I still do a lot of teaching and mentorship.”
Jianling Yuan, MD’03, PhD’02, was voted "Educator of the Year" by Association of Residents in Radiation Oncology (ARRO) in 2016, and voted "Best Doctor" by Minnesota Monthly in 2014, 2015, 2017, 2018.
Jerome Zeldis, MD’78, PhD’78, was the first MD to join Celgene Corporation and establishedClinical Research, Safety, and Medical Affairs. While at Celgene, the company grew from a Market Cap of less than $100M to more than $100B. Jerome helped make the company international. One of the drugs that hehelped to develop is the number one oncology drug in the world (lenalidomide); he has helped to get nine drugs FDA approved.
Dan Wolf, MD’01, PhD’00, was recently promoted to Associate Professor of Psychiatry with tenure at the Perelman School of Medicine at the University of Pennsylvania. He is also a faculty member in theInstitute for Translational Medicine and Therapeutics at the Perelman School of Medicine. He is married with three children ages 14, 12, 8, and reports that he lives a mile or so from Max Kelz MD’00, PhD’99, who is Associate Professor of Anesthesiology and Critical Care at the Perelman School of Medicine at the University of Pennsylvania.
Peter Ho, MD’90, PhD’90, was co-founder of BeiGene (an oncology biotech) which IPO'd in February, 2016. Peter has had a direct hand in the development of 10 FDA-approved drugs or biologics.
James Elder, MD’81, PhD’82, is the Kirk D. Wuepper Chair of Molecular Genetic Dermatology at the University of Michigan
Bradley Erkstrand, MD’97, PhD’97, is the Vice President of the Association of Northern California Oncologists. See www.anco-online.org for more information.
Don Ingber, MD’84, PhD’84, is Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, Judah Folkman Professor of Vascular Biology, Harvard Medical School & Vascular Biology Program, Boston Children’s Hospital, and Professor of Bioengineering, Harvard School of Engineering and Applied Sciences. He founded 5 companies and his work has crossed the art-science interface with multiple museum exhibitions, international design awards, and inventions in the Museum of Modern Art (MoMA) in NYC .
Robert Homer,MD’87, PhD’87, is Professor and Director of Medical Studies in the Yale School of Medicine Department of Pathology, Director of Thoracic Pathology and Director, Medical Student Course Module in Pathology.
John Jay Gargus, MD’79, PhD’79, is a Professor of Physiology & Biophysics and of Pediatrics at the the University of California-Irvine School of Medicine. He is the Founding Director of the UCI Center for Autism Research and Translation, receiving seed gift of $28M. He is also the sole USA PI on a first-in-human pivotal clinical trial in lethal Wolman Disease, receiving FDA approval. Jay discovered a biophysical IP3R single-channel functional biomarker in autism spectrum disorder.